VetMab is a veterinary biopharmaceutical company focused on developing monoclonal antibodies (mAbs) to treat debilitating diseases in dogs and cats, leveraging human-validated targets for innovative veterinary therapeutics
VetMab is a veterinary biopharmaceutical company focused on developing monoclonal antibodies (mAbs) to treat debilitating diseases in dogs and cats, leveraging human-validated targets for innovative veterinary therapeutics.